Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03278717
Title Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients (ICON9)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors University College, London

peritoneal carcinoma

fallopian tube serous adenocarcinoma

fallopian tube endometrioid adenocarcinoma

ovarian serous carcinoma

endometrioid ovary carcinoma



Cediranib + Olaparib

Age Groups: adult | senior
Covered Countries CAN

No variant requirements are available.